• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,224.84
  • 0.93 %
  • $75.57
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Quest Diagnostics Incorporated (DGX) Stock Price, News & Analysis

Quest Diagnostics Incorporated (DGX) Stock Price, News & Analysis

Currency in USD Disclaimer

$163.89

$2.57

(1.59%)

Day's range
$160.33
Day's range
$164.25
50-day range
$146.17
Day's range
$164.25
  • Country: US
  • ISIN: US74834L1008
52 wk range
$123.04
Day's range
$164.25


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 2.90
  • Piotroski Score 5.00
  • Grade Neutral
  • Symbol (DGX)
  • Company Quest Diagnostics Incorporated
  • Price $163.89
  • Changes Percentage (1.59%)
  • Change $2.57
  • Day Low $160.33
  • Day High $164.25
  • Year High $164.25

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

  • Last Earnings 11/12/2024
  • Ex-Dividend for 5/16 Dividend 01/14/2025
  • Dividend Payable 01/29/2025
  • Today N/A
  • Next Earnings (Estimated) 01/30/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $165.00
  • High Stock Price Target $190.00
  • Low Stock Price Target $140.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $7.43
  • Trailing P/E Ratio 19.16
  • Forward P/E Ratio 19.16
  • P/E Growth 19.16
  • Net Income $854.00 M

Income Statement

Quarterly

Annual

Latest News of DGX

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Quest Diagnostics Incorporated Frequently Asked Questions

  • What were the earnings of DGX in the last quarter?

    In the last quarter Quest Diagnostics Incorporated earnings were on Tuesday, October, 22nd. The Quest Diagnostics Incorporated maker reported $2.30 EPS for the quarter, beating analysts' consensus estimates of $2.26 by $0.04.

  • What is the Quest Diagnostics Incorporated stock price today?

    Today's price of Quest Diagnostics Incorporated is $163.89 — it has increased by +1.59% in the past 24 hours. Watch Quest Diagnostics Incorporated stock price performance more closely on the chart.

  • Does Quest Diagnostics Incorporated release reports?

    Yes, you can track Quest Diagnostics Incorporated's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Quest Diagnostics Incorporated stock forecast?

    Watch the Quest Diagnostics Incorporated chart and read a more detailed Quest Diagnostics Incorporated stock forecast to see what analysts suggest you do with its shares.

  • What is Quest Diagnostics Incorporated stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by Quest Diagnostics Incorporated stock ticker.

  • How to buy Quest Diagnostics Incorporated stocks?

    Like other stocks, DGX shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Quest Diagnostics Incorporated's EBITDA?

    Quest Diagnostics Incorporated measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Quest Diagnostics Incorporated’s financial statements.

  • What is the Quest Diagnostics Incorporated's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.0923043666, which equates to approximately 9.23%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Quest Diagnostics Incorporated stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Quest Diagnostics Incorporated's financials relevant news, and technical analysis. Quest Diagnostics Incorporated's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Quest Diagnostics Incorporated stock currently indicates a “sell” signal. For more insights, review Quest Diagnostics Incorporated’s technical analysis.

  • A revenue figure for Quest Diagnostics Incorporated for its last quarter?

    Quest Diagnostics Incorporated published it's last quarterly revenues at $2.49 B.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.